Kim Hyung Heon 4
4 · NeuroBo Pharmaceuticals, Inc. · Filed Aug 13, 2024
Insider Transaction Report
Form 4
Kim Hyung Heon
DirectorCEO & President
Transactions
- Tax Payment
Common Stock
2024-08-11$3.60/sh−11,467$41,281→ 66,666 total
Footnotes (2)
- [F1]Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024.
- [F2]The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.